Brief: Forward Pharma appoints Claus Bo Svendsen as CEO

Forward Pharma A/S

01/03/2017 14:15

March 1 (Reuters) - Forward Pharma A/S  FWP.O  
    * Forward Pharma appoints Claus Bo Svendsen as chief 
executive officer and plans to reorganize to reduce burn rate 
following the settlement and license agreement with biogen 
    * Forward Pharma A/S - Svendsen succeeds Peder M. Andersen 
    * Forward Pharma A/S - plans to wind up its remaining 
research and development efforts 
    * Forward Pharma A/S - Andersen will retain his role as 
chief operating officer and serve until September 1, 2017 
    * Forward Pharma A/S - plans to pursue an organizational 
realignment to reduce personnel and operating expenses by 
mid-year 2017 
 
Source text for Eikon:  urn:newsml:reuters.com:*:nGNXNQMHUa 
Further company coverage:  FWP.O  
 
 ((bangalore.newsroom@thomsonreuters.com;))